⌘K

Login Start Free

Home/Filings/4/0001493152-24-047526

4//SEC Filing

Samuelson Doug 4

Accession 0001493152-24-047526

CIK 0001962011other

View on SEC.gov Company Profile

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 6:03 AM ET

Size

4.5 KB

Accession

0001493152-24-047526

Insider Transaction Report

Form 4

Period: 2024-11-22

Kairos Pharma, LTD.KAPA

Chief Financial Officer

Transactions

Purchase
COMMON STOCK
2024-11-22$1.50/sh+2,500$3,750→ 60,796 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Kairos Pharma, LTD.

CIK 0001962011

Entity typeother

Related Parties

1

filerCIK 0001943326

Filing Metadata

Form type: 4
Filed: Nov 24, 7:00 PM ET
Accepted: Nov 25, 6:03 AM ET
Size: 4.5 KB

View on SEC.gov